Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats

Abstract

The anemia associated with chronic renal failure is one of the best target diseases for erythropoietin (Epo) gene transfer. We previously reported a short-term (1 month) study of continuous rat Epo delivery by muscle-targeted gene transfer of plasmid DNA expressing rat Epo (pCAGGS-Epo) using in vivo electroporation in normal rats. Here, we performed a long-term pharmacokinetic study of continuous Epo delivery by this method in normal rats and uremic five-sixths nephrectomized rats. In normal rats, Epo gene expression and sufficient erythropoiesis occurred with Epo gene transfer in a dose-dependent manner, and persisted for at least 11 weeks. Repeated administration of the plasmid DNA effectively produced erythropoiesis. Similar erythropoiesis was observed in the uremic rats, and persisted for more than 15 weeks. Both normal and uremic rats showed a significant decrease in platelet count. Moreover, the uremic rats showed Epo-induced hypertension, which is the major side-effect of recombinant human Epo. These results demonstrate that muscle-targeted pCAGGS-Epo transfer by in vivo electroporation is a useful procedure for the long-term continuous delivery of Epo in both normal and uremic rats.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  1. Koury MJ, Bondurant MC . Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells Science 1990 248: 378–381

    Article  CAS  Google Scholar 

  2. Ledkey FD . Nonviral gene therapy: the promise of genes as pharmaceutical products Hum Gene Ther 1995 6: 1129–1144

    Article  Google Scholar 

  3. Wolff JA et al. Direct gene transfer into mouse muscle in vivo Science 1990 247: 1465–1468

    Article  CAS  Google Scholar 

  4. Wolff JA et al. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle Hum Mol Genet 1992 1: 363–369

    Article  CAS  Google Scholar 

  5. Aihara H, Miyazaki J . Gene transfer into muscle by electroporation in vivo Nature Biotechnol 1998 16: 867–870

    Article  CAS  Google Scholar 

  6. Maruyama H et al. Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation Hum Gene Ther 2000 11: 429–437

    Article  CAS  Google Scholar 

  7. Winearls CG et al. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis Lancet 1986 2: 1175–1178

    Article  CAS  Google Scholar 

  8. Eschbach JW et al. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin N Engl J Med 1987 316: 73–78

    Article  CAS  Google Scholar 

  9. Roth D et al. Effects of recombinant human erythropoietin on renal function in chronic renal failure in predialysis patients Am J Kidney Dis 1994 24: 777–784

    Article  CAS  Google Scholar 

  10. Garcia DL, Anderson S, Rennke HG, Brenner BM . Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass Proc Natl Acad Sci USA 1988 85: 142–146

    Google Scholar 

  11. Hamamori Y, Samal B, Tian J, Kedes L . Myoblast transfer of human erythropoietin gene in a mouse model of renal failure J Clin Invest 1995 95: 1808–1813

    Article  CAS  Google Scholar 

  12. Osada S et al. Gene therapy for renal anemia in mice with polycystic kidney using an adenovirus encoding the human erythropoietin gene Kidney Int 1999 55: 1234–1240

    Article  CAS  Google Scholar 

  13. Maione D et al. Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vector Hum Gene Ther 2000 11: 859–868

    Article  CAS  Google Scholar 

  14. Osborne WRA et al. Gene therapy for long-term expression of erythropoietin in rats Proc Natl Acad Sci USA 1995 92: 8055–8058

    Article  CAS  Google Scholar 

  15. Tripathy SK et al. Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector Proc Natl Acad Sci USA 1996 93: 10876–10880

    Article  CAS  Google Scholar 

  16. Rizzuto G et al. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation Proc Natl Acad Sci USA 1999 96: 6417–6422

    Article  CAS  Google Scholar 

  17. Boel D, Heard J-M . Modulation of erythropoietin delivery from engineered muscles in mice Hum Gene Ther 1997 8: 195–204

    Article  Google Scholar 

  18. Klinman DM et al. Safe and effective regulation of hematocrit by gene gun administration of an erythropoietin-encoding DNA plasmid Hum Gene Ther 1999 10: 659–665

    Article  CAS  Google Scholar 

  19. Wells DJ, Goldspink G . Age and sex influence expression of plasmid DNA directly injected into mouse skeletal muscle FEBS Lett 1992 306: 203–205

    Article  CAS  Google Scholar 

  20. Japanese Society for Dialysis Therapy . An overview of dialysis treatment in Japan (as of 31 Dec 1998) J Jpn Soc Dial Ther 2000 33: 1–27

    Article  Google Scholar 

  21. Vicat JM et al. Muscle transfection by electroporation with high-voltage and short-pulse currents provides high-level and long-lasting gene expression Hum Gene Ther 2000 11: 909–916

    Article  CAS  Google Scholar 

  22. McDonald TP, Clift R, Cottrell MB . Large, chronic doses of erythropoietin cause thrombocytopenia in mice Blood 1992 80: 352–358

    CAS  PubMed  Google Scholar 

  23. Markham A, Bryson HM . Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications Drugs 1995 49: 232–254

    Article  CAS  Google Scholar 

  24. Berglund B, Ekblom B . Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men J Intern Med 1991 229: 125–130

    Article  CAS  Google Scholar 

  25. Poux JM et al. Uraemia is necessary for erythropoietin-induced hypertension in rats Clin Exp Pharmacol Physiol 1995 22: 769–771

    Article  CAS  Google Scholar 

  26. Lacasse-M S et al. Uremia enhances the blood pressure response to erythropoietin Clin Exp Hypertens 1997 19: 389–401

    Article  CAS  Google Scholar 

  27. Hörl WH . Genetics of the uraemic syndrome. In: Davison AM et al (eds) Oxford Textbook of Clinical Nephrology Oxford University Press: Oxford 1998 1821–1836

    Google Scholar 

  28. Niwa H, Yamamura K, Miyazaki J . Efficient selection for high-expression transfectants with a novel eukaryotic vector Gene 1991 108: 193–199

    Article  CAS  Google Scholar 

  29. Anagnostou A, Vercellotti G, Barone J, Fried W . Factors which affect erythropoiesis in partially nephrectomized and sham-operated rats Blood 1976 48: 425–433

    CAS  PubMed  Google Scholar 

  30. Ohwada K . Improvement of cardiac puncture in mice Exp Anim 1986 35: 353–355 (Japanese)

    Article  CAS  Google Scholar 

  31. Kuwahara M et al. Evaluation of a new tail-cuff method for blood pressure measurement in rats with special reference to the effects of ambient temperature Exp Anim 1991 40: 331–336

    Article  CAS  Google Scholar 

  32. Beru N, McDonald J, Lacombe C, Goldwasser E . Expression of the erythropoietin gene Mol Cell Biol 1986 6: 2571–2575

    Article  CAS  Google Scholar 

  33. Bondurant MC, Koury MJ . Anemia induces accumulation of erythropoietin mRNA in the kidney and liver Mol Cell Biol 1986 6: 2731–2733

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was partly supported by a grant to H Maruyama and M Sugawa from the Renal Anemia Foundation (Tokyo). The authors are grateful to K Yamagiwa of the Department of Medicine II, and Y Maeda and Y Yamamoto of the Institute for Laboratory Animals, Niigata University School of Medicine, for technical assistance.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maruyama, H., Ataka, K., Gejyo, F. et al. Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats. Gene Ther 8, 461–468 (2001). https://doi.org/10.1038/sj.gt.3301412

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301412

Keywords

Search

Quick links